Is Delivery of Aerosolized Medication via HFNC for Critical Asthma Effective Concurrent Therapy?

References

1. 1.↵
   1. Berlinski A

   . Pediatric aerosol therapy. Respir Care 2017;62(6):662-677.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Schuepp KG,
   2. Straub D,
   3. Möller A,
   4. Wildhaber JH

   . Deposition of aerosols in infants and children. J Aerosol Med 2004;17(2):153-156.

   OpenUrlPubMed
3. 3.
   1. Amirav I,
   2. Newhouse MT

   . Deposition of small particles in the developing lung. Paediatr Respir Rev 2012;13(2):73-78.

   OpenUrlPubMed
4. 4.↵
   1. Fink JB

   . Aerosol delivery to ventilated infant and pediatric patients. Respir Care 2004;49(6):653-665.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Weiler T,
   2. Kamerkar A,
   3. Hotz J,
   4. Ross PA,
   5. Newth CJL,
   6. Khemani RG

   . The relationship between high flow nasal cannula flow rate and effort of breathing in children. J Pediatr 2017;189:66-71.e3.

   OpenUrl
6. 6.↵
   1. Wiser RK,
   2. Smith AC,
   3. Khallouq BB,
   4. Chen JG

   . A pediatric high-flow nasal cannula protocol standardizes initial flow and expedited weaning. Pediatr Pulmonol 2021;56(5):1189-1197.

   OpenUrl
7. 7.↵
   1. Li J,
   2. Gong L,
   3. Ari A,
   4. Fink JB

   . Decrease the flow settings to improve trans-nasal pulmonary aerosol delivery via “high-flow nasal cannula” to infants and toddlers. Pediatr Pulmonol 2019;54(6):914-921.

   OpenUrl
8. 8.↵
   1. Gates R,
   2. Haynes K,
   3. Zimmerman K,
   4. Rotta A,
   5. Miller A

   . High-flow nasal cannula in pediatric critical asthma. Respir Care 2021;66(8):1240-1246